HBsAg Level as Predictor of Liver Fibrosis in HBeAg Positive Patients With Chronic Hepatitis B Virus Infection

Journal of Clinical and Experimental Hepatology

Volumn 5, Issue 3, 2015, Pages 213-220

  Goyal, Sundeep K ^a   Jain, Ashok K ^a   Dixit, Vinod K ^a   Shukla, Suneet K ^a   Kumar, Mohan ^a   Ghosh, Jayant ^a   Ranjan, Arttrika ^a   Gupta, Neha ^a   Tripathi, Manish ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Chronic HBV infection; Chronic hepatitis B; HBsAg quantification; Hepatic fibrosis; Liver fibrosis

Indexed keywords

AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHRONIC HEPATITIS B; CONTROLLED STUDY; ELASTOGRAPHY; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VIRUS REPLICATION;

EID: 84946484305     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2015.04.008     Document Type: Article

References (31)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004, 11:97-107.
2. Liaw Y.F., Chu C.M. Hepatitis B virus infection. Lancet 2009, 373:582-592.
3. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008, 5:156.
4. McMahon B.J. The natural history of chronic hepatitis B virus infection. Hepatology 2009, 49:S45-S55.
5. Dixit V.K., Panda K., Babu A.V., et al. Asymptomatic chronic hepatitis B virus infection in northern India. Indian J Gastroenterol 2007, 26:159-161.
6. Feld J.J., Heathcote E.J. Hepatitis B e antigen-positive chronic hepatitis B: natural history and treatment. Semin Liver Dis 2006, 26:116-129.
7. Seto W.K., Lai C.L., Ip P.P., et al. A large population histology study showing the lack of association between ALT elevation and significant fibrosis in chronic hepatitis B. PLoS One 2012, 7:e32622.
8. Kumar M., Sarin S.K., Hissar S., et al. Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT. Gastroenterology 2008, 134:1376-1384.
9. Liao B., Wang Z., Lin S., et al. Significant fibrosis is not rare in Chinese chronic hepatitis B patients with persistent normal ALT. PLoS One 2013, 8:e78672.
10. Srivastava M., Rungta S., Dixit V.K., et al. Predictors of survival in hepatitis B virus related decompensated cirrhosis on tenofovir therapy: an Indian perspective. Antivir Res 2013, 100:300-305.
11. Sanai F.M., Babatin M.A., Bzeizi K.I., et al. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen-negative patients with chronic hepatitis. Clin Gastroenterol Hepatol 2013, 11:1493-1499. e2.
12. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012, 57:167-185.
13. Papatheodoridis G.V., Manolakopoulos S., Liaw Y.F., et al. Follow-up and indications for liver biopsy in HBeAg-negative chronic hepatitis B virus infection with persistently normal ALT: a systematic review. J Hepatol 2012, 57:196-202.
14. Iloeje U.H., Yang H.I., Su J., et al. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006, 130:678-686.
15. Wong G.L., Wong V.W., Choi P.C., et al. Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. Clin Gastroenterol Hepatol 2009, 7:227-233.
16. Fung J., Lai C.L., Seto W.K., et al. The use of transient elastography in the management of chronic hepatitis B. Hepatol Int 2011, 22:868-875.
17. Chan H.L., Wong V.W., Tse A.M., et al. Serum hepatitis B surface antigen quantitation can reflect hepatitis B virus in the liver and predict treatment response. Clin Gastroenterol Hepatol 2007, 5:1462-1468.
18. Jaroszewicz J., Calle Serrano B., Wursthorn K., et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010, 52:514-522.
19. Nguyen T., Thompson A.J., Bowden S., et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010, 52:508-513.
20. Brunetto M.R., Oliveri F., Colombatto P., et al. Hepatitis B surface antigen serum levels help to distinguish active from inactive hepatitis B virus genotype D carriers. Gastroenterology 2010, 139:483-490.
21. Brunetto M.R., Moriconi F., Bonino F., et al. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009, 49:1141-1150.
22. Moucari R., Mackiewicz V., Lada O., et al. Early serum HBsAg drop: a strong predictor of sustained virological response to pegylated interferon alfa-2a in HBeAg-negative patients. Hepatology 2009, 49:1151-1157.
23. Cheng P.N., Tsai H.W., Chiu Y.C., et al. Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B. J Clin Virol 2013, 57:323-330.
24. Martinot-Peignoux M., Carvalho-Filho R., Lapalus M., et al. Hepatitis B surface antigen serum level is associated with fibrosis severity in treatment-naive, e antigen-positive patients. J Hepatol 2013, 58:1089-1095.
25. Seto W.K., Wong D.K., Fung J., et al. High hepatitis B surface antigen levels predict insignificant fibrosis in hepatitis B e antigen positive chronic hepatitis B. PLoS One 2012, 7:e43087.
26. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
27. Chan H.L., Wong V.W., Wong G.L., et al. A longitudinal study on the natural history of serum hepatitis B surface antigen changes in chronic hepatitis B. Hepatology 2010, 52:1232-1241.
28. Bill C.A., Summers J. Genomic DNA double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci U. S. A 2004, 101:11135-11140.
29. Thompson A., Locarnini S., Visvanathan K. The natural history and the staging of chronic hepatitis B: time for reevaluation of the virus-host relationship based on molecular virology and immunopathogenesis considerations?. Gastroenterology 2007, 133:1031-1035.
30. Srivastava M., Ranjan A., Choudhary J.K., et al. Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (Interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario. J Interferon Cytokine Res 2014, 34:547-551.
31. Chandra R., Kapoor D., Agarwal S.R., et al. Profile of asymptomatic chronic HBV infection in India. Indian J Med Res 2002, 116:50-57.